JP Morgan Initiates Coverage on Core Laboratories N.V. to Overweight

JP Morgan Initiates Coverage on Core Laboratories N.V.(NYSE:CLB). The shares have been rated Overweight. The rating by JP Morgan was issued on Jun 10, 2016.

In a different note, On May 16, 2016, Citigroup said it Maintains its rating on Core Laboratories N.V.. In the research note, the firm Raises the price-target to $115.00 per share. The shares have been rated ‘Neutral’ by the firm. On Apr 22, 2016, Cowen & Company said it Maintains its rating on Core Laboratories N.V.. In the research note, the firm Raises the price-target to $80.00 per share. The shares have been rated ‘Market Perform’ by the firm. On Apr 22, 2016, Stephens & Co. said it Maintains its rating on Core Laboratories N.V.. In the research note, the firm Raises the price-target to $89.00 per share. The shares have been rated ‘Equal-weight’ by the firm. On Apr 22, 2016, ABN Amro said it Downgrades its rating on Core Laboratories N.V.. The shares have been rated ‘Sell’ by the firm. On Apr 19, 2016, Morgan Stanley said it Maintains its rating on Core Laboratories N.V.. In the research note, the firm Raises the price-target to $120.00 per share. The shares have been rated ‘Overweight’ by the firm. Stephens & Co. said it Initiates Coverage on Core Laboratories N.V., according to a research note issued on Apr 5, 2016. The shares have been rated ‘Equal-weight’ by the firm.

Core Laboratories N.V. (CLB) shares turned negative on Wednesdays trading session with the shares closing down -0.39 points or -0.32% at a volume of 5,15,520. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $126.04. The peak price level was also seen at $126.04 while the days lowest was $122.61. Finally the shares closed at $123.05. The 52-week high of the shares is $135.49 while the 52-week low is $84.503. According to the latest information available, the market cap of the company is $5,217 M.

Core Laboratories N.V.(CLB) last announced its earnings results on Apr 20, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $153.65M. Analysts had an estimated revenue of $158.46M. Earnings per share were $0.37. Analysts had estimated an EPS of $0.37.

Several Insider Transactions has been reported to the SEC. On Feb 3, 2016, Jan Willem Sodderland (director) purchased 300 shares at $93.90 per share price.Also, On May 13, 2015, Michael C Kearney (director) sold 1,000 shares at $128.52 per share price.On Feb 3, 2015, Kempen Margaret Ann Van (director) purchased 250 shares at $102.07 per share price, according to the Form-4 filing with the securities and exchange commission.

Core Laboratories N.V. (Core Lab) is a provider of proprietary and patented reservoir description production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *